3.325
price up icon6.57%   0.205
after-market アフターアワーズ: 3.30 -0.025 -0.75%
loading
前日終値:
$3.12
開ける:
$3.21
24時間の取引高:
1.40M
Relative Volume:
1.54
時価総額:
$246.81M
収益:
$6.96M
当期純損益:
$-46.51M
株価収益率:
-19.38
EPS:
-0.1716
ネットキャッシュフロー:
$-37.99M
1週間 パフォーマンス:
+29.38%
1か月 パフォーマンス:
+48.44%
6か月 パフォーマンス:
-11.57%
1年 パフォーマンス:
-74.22%
1日の値動き範囲:
Value
$3.16
$3.57
1週間の範囲:
Value
$2.34
$3.66
52週間の値動き範囲:
Value
$1.60
$16.55

Perspective Therapeutics Inc Stock (CATX) Company Profile

Name
名前
Perspective Therapeutics Inc
Name
セクター
Healthcare (1171)
Name
電話
509-375-1202
Name
住所
350 Hills Street, Suite 106, Richland
Name
職員
91
Name
Twitter
Name
次回の収益日
2025-03-26
Name
最新のSEC提出書
Name
CATX's Discussions on Twitter

CATX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Medical Devices icon
CATX
Perspective Therapeutics Inc
3.325 200.42M 6.96M -46.51M -37.99M -0.1716
Medical Devices icon
ABT
Abbott Laboratories
133.58 231.14B 42.34B 13.50B 6.66B 7.71
Medical Devices icon
BSX
Boston Scientific Corp
102.09 154.60B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
383.89 146.12B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
87.44 105.64B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
77.52 45.60B 5.54B 4.18B 623.10M 7.00

Perspective Therapeutics Inc Stock (CATX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-03-13 開始されました H.C. Wainwright Buy
2025-03-07 開始されました Scotiabank Sector Outperform
2024-11-25 ダウングレード BofA Securities Buy → Neutral
2024-10-24 開始されました UBS Buy
2024-10-01 開始されました Wedbush Outperform
2024-09-25 開始されました Truist Buy
2024-07-25 開始されました BofA Securities Buy
2024-05-09 開始されました Cantor Fitzgerald Overweight
すべてを表示

Perspective Therapeutics Inc (CATX) 最新ニュース

pulisher
Jun 05, 2025

151,610 Shares in Perspective Therapeutics, Inc. (NYSE:CATX) Acquired by Two Sigma Advisers LP - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

ProShare Advisors LLC Acquires 5,011 Shares of Perspective Therapeutics, Inc. (NYSE:CATX) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Perspective Therapeutics (NYSE:CATX) Rating Increased to Moderate Buy at Royal Bank of Canada - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Perspective Therapeutics (NYSE:CATX) Price Target Raised to $16.00 at Royal Bank of Canada - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Perspective Therapeutics (CATX) Price Target Raised by RBC Capital | CATX Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Perspective Therapeutics (CATX) Gets a Buy from Scotiabank - The Globe and Mail

Jun 03, 2025
pulisher
Jun 03, 2025

RBC Capital Boosts Price Target for Perspective Therapeutics (CATX) | CATX Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Perspective Therapeutics Updates on Radiopharmaceutical Advancements - TipRanks

Jun 03, 2025
pulisher
Jun 03, 2025

RBC Capital raises Perspective Therapeutics stock price target to $16 By Investing.com - Investing.com Nigeria

Jun 03, 2025
pulisher
Jun 03, 2025

RBC Raises Price Target on Perspective Therapeutics to $16 From $15, Keeps Outperform, Speculative Risk - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

RBC Capital raises Perspective Therapeutics stock price target to $16 - Investing.com

Jun 03, 2025
pulisher
Jun 03, 2025

Perspective Therapeutics, Inc. (NYSE:CATX) Shares Sold by Nuveen Asset Management LLC - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Perspective Therapeutics, Inc. (NYSE:CATX) Shares Acquired by Deutsche Bank AG - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Two Sigma Investments LP Takes $2.08 Million Position in Perspective Therapeutics, Inc. (NYSE:CATX) - Defense World

Jun 02, 2025
pulisher
May 31, 2025

Perspective Therapeutics, Inc. (CATX) Reports Positive Results for NET Treatment Trial - Insider Monkey

May 31, 2025
pulisher
May 30, 2025

Perspective Therapeutics Highlights Updated Interim Data from its Ongoing Phase 1/2a Clinical Trial of [212Pb]VMT-?-NET at the 2025 ASCO Annual Meeting | CATX Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Perspective Therapeutics Provides Updated Interim Results and Safety Findings for [212Pb]VMT-α-NET at ASCO 2025 - Nasdaq

May 30, 2025
pulisher
May 30, 2025

Perspective Therapeutics Highlights Updated Interim Data from its Ongoing Phase 1/2a Clinical Trial of [212Pb]VMT-α-NET at the 2025 ASCO Annual Meeting - Yahoo Finance

May 30, 2025
pulisher
May 30, 2025

Millennium Management LLC Buys New Stake in Perspective Therapeutics, Inc. (NYSE:CATX) - Defense World

May 30, 2025
pulisher
May 29, 2025

Neuroendocrine Tumors Market: Epidemiology, Therapies, - openPR.com

May 29, 2025
pulisher
May 28, 2025

Perspective Therapeutics Announces Voting Results By Investing.com - Investing.com Canada

May 28, 2025
pulisher
May 28, 2025

Perspective Therapeutics Holds Annual Stockholders Meeting - TipRanks

May 28, 2025
pulisher
May 28, 2025

Perspective Therapeutics Announces Voting Results - Investing.com

May 28, 2025
pulisher
May 28, 2025

Northern Trust Corp Acquires 13,115 Shares of Perspective Therapeutics, Inc. (NYSE:CATX) - Defense World

May 28, 2025
pulisher
May 26, 2025

Janus Henderson Group PLC Has $57,000 Stake in Perspective Therapeutics, Inc. (NYSE:CATX) - Defense World

May 26, 2025
pulisher
May 24, 2025

Perspective Therapeutics, Inc. (NYSE:CATX) Given Consensus Rating of “Buy” by Brokerages - Defense World

May 24, 2025
pulisher
May 22, 2025

Equities Analysts Offer Predictions for CATX Q1 Earnings - Defense World

May 22, 2025
pulisher
May 22, 2025

HC Wainwright Has Pessimistic Outlook of CATX Q3 Earnings - Defense World

May 22, 2025
pulisher
May 21, 2025

Perspective Therapeutics, Inc. (CATX): Analysts See 460% Upside Potential - MSN

May 21, 2025
pulisher
May 21, 2025

Head-To-Head Review: Avinger (NASDAQ:AVGR) and Perspective Therapeutics (NYSE:CATX) - Defense World

May 21, 2025
pulisher
May 20, 2025

Perspective Therapeutics’ SWOT analysis: rare disease stock faces clinical hurdles - Investing.com Nigeria

May 20, 2025
pulisher
May 18, 2025

Mercer Global Advisors Inc. ADV Invests $51,000 in Perspective Therapeutics, Inc. (NYSE:CATX) - Defense World

May 18, 2025
pulisher
May 15, 2025

Perspective Therapeutics Reports Q1 2025 Earnings - TipRanks

May 15, 2025
pulisher
May 14, 2025

Perspective Therapeutics (CATX) Rating Maintained, Price Target Lowered | CATX Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Truist Securities Adjusts Perspective Therapeutics Price Target to $8 From $10, Maintains Buy Rating - marketscreener.com

May 14, 2025
pulisher
May 13, 2025

Oppenheimer cuts CATX stock price target to $15, maintains Outperform By Investing.com - Investing.com South Africa

May 13, 2025
pulisher
May 13, 2025

Perspective Therapeutics Provides Recent Business Highlights and Reports 1Q 2025 Results | CATX Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Oppenheimer Trims Perspective Therapeutics Price Target to $15 From $16, Maintains Outperform Rating - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Perspective Therapeutics, Inc. (NYSE:CATX) Shares Acquired by Wells Fargo & Company MN - Defense World

May 13, 2025
pulisher
May 13, 2025

Oppenheimer cuts CATX stock price target to $15, maintains Outperform - Investing.com

May 13, 2025
pulisher
May 12, 2025

Perspective Therapeutics: Q1 Earnings Snapshot - The Washington Post

May 12, 2025
pulisher
May 12, 2025

Perspective Therapeutics Inc (CATX) Q1 2025 Earnings: EPS Loss of $0.25 Beats Estimate, Revenue of $0.3M Exceeds Expectations - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Perspective Therapeutics Reports Q1 2025 Results and Updates - TipRanks

May 12, 2025
pulisher
May 12, 2025

Perspective Therapeutics Provides Recent Business Highlights and Reports 1Q 2025 Results - The Manila Times

May 12, 2025
pulisher
May 12, 2025

Perspective Therapeutics, Inc. Announces Clinical Updates and Recruitment Progress for Novel Radiopharmaceuticals Ahead of 2025 ASCO Meeting - Nasdaq

May 12, 2025
pulisher
May 12, 2025

Perspective Therapeutics (CATX) Prepares for Q1 Earnings Announcement - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Perspective Therapeutics, Inc. (NYSE:CATX) Shares Sold by Barclays PLC - Defense World

May 12, 2025
pulisher
May 08, 2025

Mariner LLC Invests $150,000 in Perspective Therapeutics, Inc. (NYSE:CATX) - Defense World

May 08, 2025
pulisher
May 05, 2025

Perspective Therapeutics Inc (AMEX: CATX): Down -84.76% In 2025, Outlook Remains Negative - Stocksregister

May 05, 2025
pulisher
May 02, 2025

Legal & General Group Plc Has $155,000 Stock Holdings in Perspective Therapeutics, Inc. (NYSE:CATX) - Defense World

May 02, 2025
pulisher
May 01, 2025

Perspective Therapeutics to Participate in Upcoming May Investor Conferences - The Manila Times

May 01, 2025

Perspective Therapeutics Inc (CATX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
medical_devices PHG
$23.46
price up icon 0.56%
medical_devices STE
$243.72
price up icon 0.06%
medical_devices SNN
$30.26
price down icon 0.13%
$71.62
price up icon 0.10%
$86.67
price up icon 1.08%
medical_devices EW
$77.52
price down icon 0.32%
大文字化:     |  ボリューム (24 時間):